Victory Capital Management
CTSO icon

Victory Capital Management’s Cytosorbents Corp CTSO Stock Holding History

Victory Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,682
Closed -$729K – 2505
2020
Q2 		$729K Buy
3,682
+3,440
+1,421% +$632K ﹤0.01% 1862
2020
Q1 		$37K Sell
242
-519
-68% -$52.4K ﹤0.01% 2610
2019
Q4 		$59K Sell
761
-250
-25% -$21.8K ﹤0.01% 2600
2019
Q3 		$102K Buy
+1,011
New +$118K ﹤0.01% 2429

Other funds holding CTSO

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Redmile Group
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sectoral Asset Management
Sectoral Asset Management Montreal, Quebec, Canada $157M AUM 41.41% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $867M AUM 20.76% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Victory Capital Management's CTSO Position: Q3 2020 in Review

Victory Capital Management sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 3,682 shares — an estimated $729K sold.

Victory Capital Management first reported a position in CTSO in Q3 2019 and held it in 4 quarters. The position peaked at $729K in Q2 2020. 95 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • Victory Capital Management reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • Victory Capital Management sold 3,682 Cytosorbents Corp shares in Q3 2020, an estimated $729K.
  • Victory Capital Management first reported a position in Cytosorbents Corp in Q3 2019 and held it in 4 quarters.
  • Victory Capital Management's Cytosorbents Corp position peaked at $729K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on Victory Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.